Redmond image 1142x160

Investing in China: Navigating Q1 amid economic challenges

Quarterly Outlook

Summary:  China's political meetings in Q4 of 2023 reveal a lack of urgency in prioritising counter-cyclical initiatives. The direction of development strategies hinges on the Q1 2024 Third Plenum. Technology, advanced manufacturing, energy, and green metals may provide fertile ground for medium-term growth, despite challenges and uncertainty.


Decoding Q1: Insights from recent political meetings

The Central Financial Work Conference (CFWC), Politburo meeting, and Central Economic Work Conference (CEWC) convened in Q4 of 2023 to offer a glimpse into China's future policy landscape. 

Notably, the CFWC's official communication sidestepped discussions on deleveraging, opting instead to address risks within the property sector. However, a less accommodating message was sent in an article in Qiushi, a Party mouthpiece, underscoring President Xi’s directives at the conference to adhere to Marxist political economy theories for reforming the financial system. Intriguingly, the article, marked by 23 references to "risks", conspicuously avoided mentioning resolving property sector risks or local government debts. The overarching theme stressed Party control over the financial system.

In the subsequent CEWC, President Xi prioritised "seeking progress while ensuring stability" and "high-quality development", which are codes that downplay economic growth. Among the nine 2024 priorities, "developing new industries and business models through technological innovation" takes precedence. These priorities lack urgency for counter-cyclical policies. Echoing the readout from the latest Politburo meeting, the CEWC hinted at fiscal and industrial policy escalation, with stable monetary policies, side-lining short-term growth stimulation.

To avert China’s growth decline, imperative measures include productivity enhancement, and restoring entrepreneurial confidence. In addition, property sector debts will need to be restructured and projects taken over. The critical period of Q1 2024 will serve as a litmus test. Post-Third Plenum, a clearer understanding of China's economic policies and strategic directions will emerge. Presently, navigating through the macroeconomic landscape involves a degree of uncertainty.

Don’t predict, do prepare 

It’s time to remain humble, cautious and flexible as market conditions evolve. We’re not able to see the future through a fictional gap in the curtain as in John Buchan’s classic. This doesn’t mean we should disregard the macro contextual conditions or be led by the narratives of the day. As Howard Marks, founder of Oaktree Capital Management, emphasises: “We can’t predict, but we can prepare. An awareness of the economic, credit, and sentiment cycles can help with investment.”

Sowing seeds in fertile ground

  1. Technology and advanced manufacturing: Unless we hear something dramatically different from the Third Plenum, enhancing productivity and technology self-reliance will remain the two structural themes of China’s long-term development strategy. These are unlikely to wither despite the cyclical swings of the economy. The technology and advanced manufacturing companies that produce tangible products tend to benefit from favourable industrial policies. Examples include: Xiaomi, Zhejiang Sanhua Intelligent Controls, Luxshare Precision, Shenzhen Inovance, and ETFs that focus on these industries.

  2. Energy and green metals: Energy security, green transformation, and food security are enduring themes that will continue to receive policy support. Companies such as CNOOC, PetroChina, Zijin Mining, and Ganfeng Lithium align with these themes.

  3. Internet and Consumer Discretionary: While categories 1 and 2 above provide grounds for gradually sowing seeds to participate in secular trends and ride the industrial policy tailwinds, trading opportunities may arise in Internet stocks and consumer discretionary counters. This option is for more nimble traders who have a view on the momentum of the cyclical recovery of the Chinese economy. Alternatively, these stocks can serve as instruments for trading based on reading the tea leaves during Q1 in anticipation of the Third Plenum and the Two-Session meetings, as well as responses to the outcome of those meetings. 

Note: Company’s mentioned are for illustration and inspiration purposes only, and not for investment advice.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.